Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derrick Maley

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Combinatorial Chemistry & High Throughput Screening|December 8, 2004
Multiplexed RT- PCR for high throughput screening applicationsDerrick Maley, Jay Mei, Hong Lu, et al.
Biochemical and Biophysical Research Communications|November 19, 2003
Kinetic profile of a heterocyclic HCV replicon RNA synthesis inhibitorVictor K Johnston, Derrick Maley, Robert C Gagnon, et al.
Molecular Cancer Therapeutics|December 10, 2020
Preclinical Characterization of Linrodostat Mesylate, a Novel, Potent, and Selective Oral Indoleamine 2,3-Dioxygenase 1 InhibitorAaron Balog, Tai-An Lin, Derrick Maley, et al.
Methods (San Diego, Calif.)|November 26, 2005
Integrated expressional analysis: application to the drug discovery processSergey E Ilyin, Daniel Horowitz, Stanley M Belkowski, et al.
Biochemical and Biophysical Research Communications|December 20, 2003
Mapping cooperative activity of the hepatitis C virus RNA-dependent RNA polymerase using genotype 1a-1b chimerasBaohua Gu, Lester L Gutshall, Derrick Maley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2018
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-formMicah T Nelp, Patrick A Kates, John T Hunt, et al.
Virology|August 16, 2003
Enzymatic activities of the GB virus-B RNA-dependent RNA polymeraseC T Ranjith-Kumar, Jan Lee Santos, Lester L Gutshall, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer ImmunotherapyLiping Zhang, Emily C Cherney, Xiao Zhu, et al.
The Journal of Biological Chemistry|August 9, 2002
Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymeraseDashyant Dhanak, Kevin J Duffy, Victor K Johnston, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1Emily C Cherney, Liping Zhang, Susheel Nara, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Combinatorial Chemistry & High Throughput Screening|December 8, 2004
Multiplexed RT- PCR for high throughput screening applicationsDerrick Maley, Jay Mei, Hong Lu, et al.
Biochemical and Biophysical Research Communications|November 19, 2003
Kinetic profile of a heterocyclic HCV replicon RNA synthesis inhibitorVictor K Johnston, Derrick Maley, Robert C Gagnon, et al.
Molecular Cancer Therapeutics|December 10, 2020
Preclinical Characterization of Linrodostat Mesylate, a Novel, Potent, and Selective Oral Indoleamine 2,3-Dioxygenase 1 InhibitorAaron Balog, Tai-An Lin, Derrick Maley, et al.
Methods (San Diego, Calif.)|November 26, 2005
Integrated expressional analysis: application to the drug discovery processSergey E Ilyin, Daniel Horowitz, Stanley M Belkowski, et al.
Biochemical and Biophysical Research Communications|December 20, 2003
Mapping cooperative activity of the hepatitis C virus RNA-dependent RNA polymerase using genotype 1a-1b chimerasBaohua Gu, Lester L Gutshall, Derrick Maley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2018
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-formMicah T Nelp, Patrick A Kates, John T Hunt, et al.
Virology|August 16, 2003
Enzymatic activities of the GB virus-B RNA-dependent RNA polymeraseC T Ranjith-Kumar, Jan Lee Santos, Lester L Gutshall, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer ImmunotherapyLiping Zhang, Emily C Cherney, Xiao Zhu, et al.
The Journal of Biological Chemistry|August 9, 2002
Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymeraseDashyant Dhanak, Kevin J Duffy, Victor K Johnston, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1Emily C Cherney, Liping Zhang, Susheel Nara, et al.
Pageof 2